Published on 18 Dec 2023 on Simply Wall St. via Yahoo Finance
Artivion, Inc. (NYSE:AORT) Soars 36% But It's A Story Of Risk Vs Reward
Artivion, Inc. (NYSE:AORT) shareholders would be excited to see that the share price has had a great month, posting a 36% gain and recovering from prior weakness. The last 30 days bring the annual gain to a very sharp 50%.
Although its price has surged higher, Artivion may still be sending buy signals at present with its price-to-sales (or "P/S") ratio of 2.2x, considering almost half of all companies in the Medical Equipment industry in the United States have P/S ratios greater than 3.1x and even P/S higher than 8x aren't out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.
View our latest analysis for Artivion